Genetic Technology--Life Science Trends across EU5 (Germany, France, Italy, Spain, and UK)

USD 250.00

* Required Fields

USD 250.00


Be the first to review this product

This technology opportunity engine (TOE) service depicts the current landscape and the new life sciences trends across EU5 (Germany, France, Italy, Spain, and UK). The study is focused on DNA-based drug solutions for oncological and infectious diseases, as well as, innovations in cell therapy by evaluating approvals in stem cell-based therapies, and novel antigen-specific T cells platforms. A section with the acute perspective of our analysts about cell-based therapies across EU5 is included, followed by the introduction of the patent scenario associated with these technologies and regions. All industry interactions including main contacts are mapped.Keywords: Life science, DNA, drug solutions, oncological and

Table of Contents

Genetic Technology--Life Science Trends across EU5 (Germany, France, Italy, Spain, and UK)Region Overview Life Science Trends in EU5Region-Based Technology ProfilesNovel DNA-based Drug Solutions for Oncological and Infectious DiseasesFirst Stem Cell-based Therapy Approved in EuropeUsing Novel Antigen-specific T Cells Platforms for Development of Cell TherapiesStrategic PerspectivesStrategic PerspectivesAppendixPatent ScenarioPatent ScenarioIndustry Interactions

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.